APA

McArthur G. A., Maio M., Arance A., Nathan P., Blank C., Avril M., Garbe C., Hauschild A., Schadendorf D., Hamid O., Fluck M., Thebeau M., Schachter J., Kefford R., Chamberlain M., Makrutzki M., Robson S., Gonzalez R. & Margolin K. (20171221). Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

McArthur G A, Maio M, Arance A, Nathan P, Blank C, Avril M-F, Garbe C, Hauschild A, Schadendorf D, Hamid O, Fluck M, Thebeau M, Schachter J, Kefford R, Chamberlain M, Makrutzki M, Robson S, Gonzalez R and Margolin K. 20171221. Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

McArthur G. A., Maio M., Arance A., Nathan P., Blank C., Avril M., Garbe C., Hauschild A., Schadendorf D., Hamid O., Fluck M., Thebeau M., Schachter J., Kefford R., Chamberlain M., Makrutzki M., Robson S., Gonzalez R. and Margolin K. (20171221). Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

McArthur G A, Maio M, Arance A, Nathan P, Blank C, Avril M-F, Garbe C, Hauschild A, Schadendorf D, Hamid O, Fluck M, Thebeau M, Schachter J, Kefford R, Chamberlain M, Makrutzki M, Robson S, Gonzalez R and Margolin K. Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20171221.